P36 Can Real-World Evidence (RWE) Drive European, UK, and US Payer Decisions in the Reassessment of Oncology Therapies?
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.048
https://www.valueinhealthjournal.com/article/S1098-3015(22)02250-1/fulltext
Title :
P36 Can Real-World Evidence (RWE) Drive European, UK, and US Payer Decisions in the Reassessment of Oncology Therapies?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)02250-1&doi=10.1016/j.jval.2022.09.048
First page :
Section Title :
Open access? :
No
Section Order :
12245